Triple Antithrombotic Therapy Is the Independent Predictor for the Occurrence of Major Bleeding Complications | Zendy

Yoshihisa Naruse | Zendy; Akira Sato | Zendy; Tomoya Hoshi | Zendy; Noriyuki Takeyasu | Zendy; Yuki Kakefuda | Zendy; Mayu Ishibashi | Zendy; Masako Misaki | Zendy; Daisuke Abe | Zendy; Kazutaka Aonuma | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Triple Antithrombotic Therapy Is the Independent Predictor for the Occurrence of Major Bleeding Complications

Author(s) -

Yoshihisa Naruse,

Akira Sato,

Tomoya Hoshi,

Noriyuki Takeyasu,

Yuki Kakefuda,

Mayu Ishibashi,

Masako Misaki,

Daisuke Abe,

Kazutaka Aonuma

Publication year - 2013

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.113.000179

Subject(s) - interquartile range , medicine , antithrombotic , percutaneous coronary intervention , hazard ratio , warfarin , surgery , cardiology , stroke (engine) , confidence interval , myocardial infarction , atrial fibrillation , mechanical engineering , engineering

Triple antithrombotic therapy increases the risk of bleeding events in patients undergoing percutaneous coronary intervention. However, it remains unclear whether good control of percent time in therapeutic range is associated with reduced occurrence of bleeding complications in patients undergoing triple antithrombotic therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research